Tivic Health Systems, Inc.
TIVC · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $146 | $86 | $70 | $180 |
| % Growth | 69.8% | 22.9% | -61.1% | – |
| Cost of Goods Sold | $291 | $32 | $20 | $419 |
| Gross Profit | -$145 | $54 | $50 | -$239 |
| % Margin | -99.3% | 62.8% | 71.4% | -132.8% |
| R&D Expenses | $858 | $655 | $335 | $333 |
| G&A Expenses | $0 | $907 | $1,042 | $730 |
| SG&A Expenses | $1,480 | $1,333 | $1,221 | $971 |
| Sales & Mktg Exp. | $0 | $426 | $179 | $241 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $2,338 | $1,988 | $1,556 | $1,304 |
| Operating Income | -$2,483 | -$1,934 | -$1,506 | -$1,543 |
| % Margin | -1,700.7% | -2,248.8% | -2,151.4% | -857.2% |
| Other Income/Exp. Net | -$113 | $3 | $4 | $66 |
| Pre-Tax Income | -$2,596 | -$1,931 | -$1,502 | -$1,477 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$2,596 | -$1,931 | -$1,502 | -$1,477 |
| % Margin | -1,778.1% | -2,245.3% | -2,145.7% | -820.6% |
| EPS | -1.97 | -2.19 | -2.52 | -3.2 |
| % Growth | 10% | 13.1% | 21.3% | – |
| EPS Diluted | -1.97 | -2.19 | -2.52 | -3.2 |
| Weighted Avg Shares Out | 1,321 | 881 | 596 | 96 |
| Weighted Avg Shares Out Dil | 1,321 | 881 | 596 | 96 |
| Supplemental Information | – | – | – | – |
| Interest Income | $4 | $3 | $4 | $6 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $273 |
| EBITDA | -$2,596 | -$1,933 | -$1,506 | -$1,270 |
| % Margin | -1,778.1% | -2,247.7% | -2,151.4% | -705.6% |